19 March 2013
For immediate release
Reckitt Benckiser Group plc
Irrevocable, Non-Discretionary Share Repurchase Programme
On 18 February 2013, Reckitt Benckiser Group plc announced it was commencing a
share re-purchase programme of up to a maximum 6,000,000 Ordinary Shares of 10p
each (Shares). To date, 2,080,835 Shares have been re-purchased under this
programme and are held as Treasury shares.
Reckitt Benckiser Group plc today announces that it will commence an
irrevocable, non-discretionary programme with Barclays Capital Securities
Limited to purchase Shares on its own behalf during the period which commences
on 20 March and ends no later than 2 May 2013, therefore running through its
close period, 2-21 April.
Any purchases by Reckitt Benckiser Group plc under the programme will be made
within certain pre-set parameters and limits and in accordance with both
Reckitt Benckiser Group plc's general authority to repurchase shares and the
Listing Rules. Shares repurchased will be held as Treasury shares.
Contacts:
Liz Richardson Reckitt Benckiser Group plc 01753 217800
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.